Citigroup’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,506
Closed -$54K 5225
2021
Q2
$54K Sell
2,506
-34,977
-93% -$754K ﹤0.01% 4115
2021
Q1
$739K Buy
37,483
+5,337
+17% +$105K ﹤0.01% 2582
2020
Q4
$635K Buy
32,146
+6,024
+23% +$119K ﹤0.01% 2481
2020
Q3
$459K Buy
26,122
+2,747
+12% +$48.3K ﹤0.01% 2302
2020
Q2
$420K Buy
23,375
+2,662
+13% +$47.8K ﹤0.01% 2679
2020
Q1
$310K Buy
20,713
+6,805
+49% +$102K ﹤0.01% 2586
2019
Q4
$242K Buy
13,908
+5,977
+75% +$104K ﹤0.01% 3037
2019
Q3
$120K Buy
7,931
+5,787
+270% +$87.6K ﹤0.01% 3349
2019
Q2
$36K Buy
2,144
+86
+4% +$1.44K ﹤0.01% 4298
2019
Q1
$35K Hold
2,058
﹤0.01% 4244
2018
Q4
$31K Buy
2,058
+57
+3% +$859 ﹤0.01% 4198
2018
Q3
$41K Buy
2,001
+39
+2% +$799 ﹤0.01% 4198
2018
Q2
$37K Buy
1,962
+28
+1% +$528 ﹤0.01% 4050
2018
Q1
$37K Buy
1,934
+40
+2% +$765 ﹤0.01% 3932
2017
Q4
$37K Buy
1,894
+76
+4% +$1.49K ﹤0.01% 3953
2017
Q3
$39K Sell
1,818
-2
-0.1% -$43 ﹤0.01% 3758
2017
Q2
$38K Sell
1,820
-93,701
-98% -$1.96M ﹤0.01% 3707
2017
Q1
$1.85M Sell
95,521
-23,794
-20% -$461K ﹤0.01% 1484
2016
Q4
$2.03M Buy
119,315
+72,763
+156% +$1.24M ﹤0.01% 1837
2016
Q3
$872K Buy
46,552
+40,807
+710% +$764K ﹤0.01% 2038
2016
Q2
$98K Sell
5,745
-45,191
-89% -$771K ﹤0.01% 3327
2016
Q1
$914K Buy
50,936
+44,995
+757% +$807K ﹤0.01% 2144
2015
Q4
$140K Sell
5,941
-27,275
-82% -$643K ﹤0.01% 3328
2015
Q3
$748K Buy
33,216
+27,501
+481% +$619K ﹤0.01% 1920
2015
Q2
$161K Sell
5,715
-491
-8% -$13.8K ﹤0.01% 2897
2015
Q1
$171K Buy
6,206
+687
+12% +$18.9K ﹤0.01% 3072
2014
Q4
$137K Buy
5,519
+4,191
+316% +$104K ﹤0.01% 3429
2014
Q3
$29K Buy
1,328
+525
+65% +$11.5K ﹤0.01% 4026
2014
Q2
$17K Buy
803
+15
+2% +$318 ﹤0.01% 4259
2014
Q1
$17K Buy
788
+103
+15% +$2.22K ﹤0.01% 4579
2013
Q4
$14K Sell
685
-803
-54% -$16.4K ﹤0.01% 4721
2013
Q3
$29K Buy
1,488
+826
+125% +$16.1K ﹤0.01% 4056
2013
Q2
$12K Buy
+662
New +$12K ﹤0.01% 4390